These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2568457)

  • 21. Transport of hypoxanthine from plasma to cerebrospinal fluid and vitreous humor in newborn pigs.
    Rootwelt T; Oyasaeter S; Saugstad OD
    J Perinat Med; 1993; 21(3):211-7. PubMed ID: 8229612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid-chromatographic measurements of inosine, hypoxanthine, and xanthine in studies of fructose-induced degradation of adenine nucleotides in humans and rats.
    Kurtz TW; Kabra PM; Booth BE; Al-Bander HA; Portale AA; Serena BG; Tsai HC; Morris RC
    Clin Chem; 1986 May; 32(5):782-6. PubMed ID: 3698269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in microdialysis samples using microbore column high-performance liquid chromatography with a diode array detector.
    Mei DA; Gross GJ; Nithipatikom K
    Anal Biochem; 1996 Jun; 238(1):34-9. PubMed ID: 8660582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemiluminescent determination of adenosine, inosine, and hypoxanthine/xanthine.
    Kather H; Wieland E; Waas W
    Anal Biochem; 1987 May; 163(1):45-51. PubMed ID: 3619030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine, inosine, and hypoxanthine/xanthine measured in tissue and plasma by a luminescence method.
    Jabs CM; Neglen P; Eklof B; Thomas EJ
    Clin Chem; 1990 Jan; 36(1):81-7. PubMed ID: 2297938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purine metabolites in the CSF in presenile and senile dementia of Alzheimer type, and in multi infarct dementia.
    Degrell I; Niklasson F
    Arch Gerontol Geriatr; 1988 Jun; 7(2):173-8. PubMed ID: 3415397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in cerebrospinal fluid uridine, hypoxanthine, and xanthine in head-injured patients.
    Mueller RA; Rosner MJ; Ghia JN; Powers SK; Kafer ER; Hunt RD
    Cell Mol Neurobiol; 1988 Jun; 8(2):235-43. PubMed ID: 3409270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous determination of inosine, hypoxanthine, xanthine, and uric acid and the effect of metal chelators.
    Ferraris SP; Lew H; Elsayed NM
    Anal Biochem; 1991 May; 195(1):116-21. PubMed ID: 1888007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced ATP and GTP synthesis from hypoxanthine or inosine after myocardial ischemia.
    Harmsen E; de Tombe PP; de Jong JW; Achterberg PW
    Am J Physiol; 1984 Jan; 246(1 Pt 2):H37-43. PubMed ID: 6198929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of hyperglycemia on cerebral adenosine production during ischemia and reperfusion.
    Hsu SS; Meno JR; Zhou JG; Gordon EL; Winn HR
    Am J Physiol; 1991 Aug; 261(2 Pt 2):H398-403. PubMed ID: 1877666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of uric acid from perfused rat heart.
    Ronca-Testoni S; Borghini F
    Ital J Biochem; 1982; 31(2):127-38. PubMed ID: 7129855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid nucleotide metabolites following non-convulsive status epilepticus.
    Livingston JH; Brown JK; Harkness RA; McCreanor GM
    Dev Med Child Neurol; 1989 Apr; 31(2):168-73. PubMed ID: 2737369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The concentrations of xanthine and hypoxanthine in cerebrospinal fluid as therapeutic guides in hydrocephalus.
    Castro-Gago M; Lojo S; Del Rio R; Rodriguez A; Novo I; Rodriguez-Segade S
    Childs Nerv Syst; 1986; 2(3):109-11. PubMed ID: 3779664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Purine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase deficiency].
    López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Pascual Castroviejo I; Ortiz Vázquez J
    Med Clin (Barc); 1989 Feb; 92(5):167-70. PubMed ID: 2725104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporation of adenosine and its metabolites into brain nucleotides.
    Winn HR; Park TS; Curnish RR; Rubio R; Berne RM
    Am J Physiol; 1980 Aug; 239(2):H212-9. PubMed ID: 7406058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of biochemical markers in cerebrospinal fluid in patients with meningoencephalitis.
    Ronquist G; Callerud T; Niklasson F; Friman G
    Infect Immun; 1985 Jun; 48(3):729-34. PubMed ID: 3997245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Early changes of oxypurines in rat brain following focal cerebral ischemia].
    Nihei H
    No To Shinkei; 1988 Aug; 40(8):713-9. PubMed ID: 3179084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?
    Niklasson F; Agren H; Hällgren R
    J Neurol Neurosurg Psychiatry; 1983 Mar; 46(3):255-60. PubMed ID: 6188805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral uric acid, xanthine, and hypoxanthine after ischemia: the effect of allopurinol.
    Nihei H; Kanemitsu H; Tamura A; Oka H; Sano K
    Neurosurgery; 1989 Oct; 25(4):613-7. PubMed ID: 2797398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-mortem oxypurine concentrations in the CSF.
    Manzke H; Krämer M; Dörner K
    Adv Exp Med Biol; 1986; 195 Pt A():587-91. PubMed ID: 3728185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.